title: Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.
authors.forename: A U
authors.initials: AU
authors.lastname: Wells
authors.forename: J
authors.initials: J
authors.lastname: Behr
authors.forename: U
authors.initials: U
authors.lastname: Costabel
authors.forename: V
authors.initials: V
authors.lastname: Cottin
authors.forename: V
authors.initials: V
authors.lastname: Poletti
mesh_terms: D000111:Acetylcysteine / Q000008:administration & dosage* / Q000009:adverse effects; D001379:Azathioprine / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005100:Expectorants / Q000008:administration & dosage / Q000009:adverse effects; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy* / Q000401:mortality*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D011239:Prednisolone / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D005100:Expectorants; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011239:Prednisolone; D001379:Azathioprine; D000111:Acetylcysteine